The nation of Zimbabwe has declined a major American health deal valued at 367 million US dollars (£272m) spanning five years because of Washington's demand for sensitive data.
This rejection came to light after a government memo dated December was disclosed, revealing that President Emmerson Mnangagwa felt the deal was "lopsided".
An official representative has since clarified that the United States was requesting biological samples for research and profit while was unwilling to share the benefits from any future vaccines.
"We will now turn to the challenging and unfortunate process of winding down our support in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont publicly.
Her embassy said the United States had provided more than $1.9bn in health funding to Zimbabwe during the past twenty years.
A doctors' association in Zimbabwe has appealed for more negotiations to find a agreement suitable to all parties so the country's vital HIV treatment initiative can proceed.
Wider Implications
This rejection follows a similar situation in neighbouring Kenya, where a court halted a related deal with the US after concerns were raised about the safety of citizens' health data.
Since resuming the presidency last year, US President Donald Trump has reduced foreign aid and shut down the key foreign aid agency.
The agency had managed assistance for the American government, but Trump stated its spending was "wasteful" and his government was seeking government-to-government deals to boost transparency and responsibility.
As per reports, Sixteen African countries have so far signed these new agreements, representing over $18.3bn in new funding.
Specifics of the Declined Agreement
The money for Zimbabwe would have funded "HIV/Aids treatment and prevention, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".
"We are confident this partnership might have yielded extraordinary benefits for the people of Zimbabwe, especially the 1.2 million currently receiving antiretroviral therapy via American-funded initiatives," Tremont said.
However, government spokesperson Nick Mangwana argued the proposed deal was "unfair".
"Zimbabwe was being asked to provide its genetic material and health information over an extended period, with no equivalent guarantee of benefiting from any scientific breakthroughs – like new medicines or tests – that might be developed from that provided information," his statement read.
"Effectively, our country would supply the raw materials for scientific discovery without any certainty that the resulting innovations would be accessible to our people should a new disease outbreak emerge."
National Interest and Global Health
He also said that the American exit from the World Health Organization (WHO) and its push of one-on-one health agreements were disrupting structures previously set up through the global organization.
The spokesperson gave as an example its Pathogen Access and Benefit Sharing system designed to deal with future pandemics.
"This mechanism is designed to guarantee that when a nation contributes its data, the resulting advantages – including vaccines and treatments – are shared equitably, not commercialised exclusively by those with the funds to create them."
Zimbabwe's reservations over the US deal "should not be misconstrued as hostility towards the US," Mangwana stressed.
"We are open to further dialogue with our American counterparts on how subsequent co-operation could be arranged in a manner that honours the independence and dignity of both nations."
Medical Community Response
Medical experts stated it understood the official position, but recommended that negotiations should continue given that a large portion of the nation's HIV programmes were funded by external financing.
"Where specific concerns arise, such as those involving data governance or implementation frameworks, these can often be resolved through technical clarification and mutually agreed protections," the group commented.
The situation highlights the continuing tensions between receiving crucial international aid and safeguarding national sovereignty in an ever more interconnected world.